Machine Learning

IEEE-USA is launching BiG Thinkers, a new event uniting leaders from Disney, OpenAI, and Pixar to cultivate creativity and leadership in tech professionals.

Documo’s award-winning AI platform is turning the tide on healthcare's reliance on fax, automating paperwork to reduce staff burnout and improve patient care.

Alkeus Pharmaceuticals will present crucial data on its oral drug for Stargardt disease, a leading cause of juvenile blindness with no current cure.

BsStrategy's latest platform update signals a major shift in AI finance, where robust infrastructure and risk control are eclipsing the hunt for magic algorithms.

With fresh capital, the Swedish biotech is scaling its revolutionary platform that decodes cellular communication, fueling a major US expansion.

A Boston biotech is using AI and targeted mRNA to program cells inside the body, aiming to make complex CAR T treatments safer and universally accessible.

A tiny brush, engineered to micron-level precision, is at the forefront of a high-tech shift in medical manufacturing, enabling the future of robotics and AI.

New pre-clinical data shows engineered immune cells (iMacrophages) can effectively target and destroy ovarian tumors, offering hope for a new treatment era.

A new IDEO report quantifies how specific workplace behaviors create a $10 billion profit gap, proving that how a company operates is its biggest asset.

Biotech firm Scribe Therapeutics, co-founded by a Nobel laureate, is pioneering a new gene therapy for high cholesterol that silences genes, not cuts them.

A new system from OSHIMA goes beyond simple defect detection, integrating AI inspection with spreading and cutting for a seamless smart factory workflow.

A new imaging agent could slash the years-long diagnostic delay for endometriosis, offering hope to millions of women suffering from the debilitating condition.

Swiss medtech firm CorFlow is tackling a major post-heart attack complication with two pivotal trials, aiming to create a new standard of care.

A new platform is launching AI-powered interviews and scheduling at a fraction of the cost of enterprise tools, promising to change how businesses hire.

New research challenges long-held beliefs, revealing a high-risk subset in "safe" tumors and a surprising link between body weight and cancer recurrence.

Jumio launches Watch, a continuous identity intelligence service to combat evolving risks like deepfakes and synthetic identities long after onboarding.

Hedgehog releases OCP-accepted AI network blueprints, aiming to democratize AI infrastructure with open, cost-effective Ethernet-based designs.

Arkay Beverages plans a global network of zero-proof bars, banking on a unique molecule and a $1.5B NASDAQ goal. But can it deliver a true alternative?

Taiwanese firm Smart Power System unveils an AI-driven strategy to build disaster-proof microgrids and export its advanced energy technology worldwide.

South Korea approves its first homegrown CAR-T therapy, a landmark achievement offering new hope for lymphoma patients with impressive response rates.